Australija - anglų - Department of Health (Therapeutic Goods Administration)

astellas pharma australia pty ltd - tacrolimus, quantity: 1 mg - capsule, modified release - excipient ingredients: hypromellose; iron oxide yellow; gelatin; sodium lauryl sulfate; titanium dioxide; ethylcellulose; iron oxide red; magnesium stearate; lactose monohydrate; hyprolose; butan-1-ol; purified water; industrial methylated spirit; simethicone; lecithin; ethanol; shellac; strong ammonia solution; sulfuric acid - prograf-xl is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

astellas pharma australia pty ltd - tacrolimus, quantity: 0.5 mg - capsule, modified release - excipient ingredients: iron oxide yellow; hypromellose; iron oxide red; titanium dioxide; lactose monohydrate; ethylcellulose; magnesium stearate; sodium lauryl sulfate; gelatin; hyprolose; butan-1-ol; purified water; industrial methylated spirit; simethicone; lecithin; ethanol; shellac; strong ammonia solution; sulfuric acid - prograf-xl is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

astellas pharma us inc. - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus 0.3 mg in 1 g - protopic ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy  for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. protopic ointment is not indicated for children younger than 2 years of age (see boxed warning, warnings and precautions: pediatric use). protopic (tacrolimus) ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.

Singapūras - anglų - HSA (Health Sciences Authority)

astellas pharma singapore pte. ltd. - tamsulosin hydrochloride - tablet, film coated, extended release - 0.4mg/tablet - tamsulosin hydrochloride 0.4 mg

Singapūras - anglų - HSA (Health Sciences Authority)

astellas pharma singapore pte. ltd. - tacrolimus - capsule - 0.5 mg - tacrolimus 0.5 mg

Singapūras - anglų - HSA (Health Sciences Authority)

astellas pharma singapore pte. ltd. - tacrolimus - capsule - 1 mg - tacrolimus 1 mg

Singapūras - anglų - HSA (Health Sciences Authority)

astellas pharma singapore pte. ltd. - tacrolimus - capsule - 5 mg - tacrolimus 5 mg

Singapūras - anglų - HSA (Health Sciences Authority)

astellas pharma singapore pte. ltd. - tacrolimus - injection - 5 mg/ml - tacrolimus 5 mg/ml

Singapūras - anglų - HSA (Health Sciences Authority)

astellas pharma singapore pte. ltd. - micafungin sodium 50.86 mg equivalent to micafungin - injection, powder, lyophilized, for solution - 50 mg/vial - micafungin sodium 50.86 mg equivalent to micafungin 50 mg/vial

Singapūras - anglų - HSA (Health Sciences Authority)

astellas pharma singapore pte. ltd. - tacrolimus monohydrate 0.51 mg eqv anhydrous tacrolimus 0.5 mg - capsule, extended release - 0.5 mg - tacrolimus monohydrate 0.51 mg eqv anhydrous tacrolimus 0.5 mg 0.5 mg